Free Trial

NexImmune (NEXI) Competitors

NexImmune logo

NEXI vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CALA

Should you be buying NexImmune stock or one of its competitors? The main competitors of NexImmune include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry.

NexImmune vs. Its Competitors

NexImmune (NASDAQ:NEXI) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and media sentiment.

9.9% of NexImmune shares are held by institutional investors. 14.9% of NexImmune shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

180 Life Sciences' return on equity of 0.00% beat NexImmune's return on equity.

Company Net Margins Return on Equity Return on Assets
NexImmuneN/A -534.32% -213.72%
180 Life Sciences N/A N/A N/A

In the previous week, 180 Life Sciences had 1 more articles in the media than NexImmune. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for NexImmune. 180 Life Sciences' average media sentiment score of 1.87 beat NexImmune's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
NexImmune Neutral
180 Life Sciences Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NexImmuneN/AN/A-$32.34M-$18.54N/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

180 Life Sciences beats NexImmune on 4 of the 6 factors compared between the two stocks.

Get NexImmune News Delivered to You Automatically

Sign up to receive the latest news and ratings for NEXI and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NEXI vs. The Competition

MetricNexImmunePharmaceutical IndustryMedical SectorNASDAQ Exchange
Market CapN/A$839.03M$5.60B$9.11B
Dividend YieldN/A4.84%5.24%4.02%
P/E Ratio0.001.1727.9620.25
Price / SalesN/A241.37430.5799.61
Price / CashN/A17.6937.4658.16
Price / BookN/A6.528.045.49
Net Income-$32.34M-$23.68M$3.18B$250.27M

NexImmune Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NEXI
NexImmune
N/AN/AN/AN/A$0.00N/A0.006
ATNFW
180 Life Sciences
N/A$0.01
+2.5%
N/A-2.4%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
flat
N/A-83.4%$0.00N/A0.002
AIMDW
Ainos
N/A$0.12
-0.2%
N/A+70.4%$0.00$106.21K0.0040Gap Up
ALVOW
Alvotech
N/A$1.90
+9.8%
N/A-42.1%$0.00$585.60M0.004Positive News
Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
flat
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.09
-14.2%
N/A+213.1%$0.00$38.00M0.0070Positive News
Gap Up
BTMDW
biote
N/A$0.01
+20.1%
N/A-97.5%$0.00$199.38M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.07
+1.0%
N/A-62.1%$0.00N/A0.008Gap Down
CALA
Calithera Biosciences
N/A$0.00
flat
N/A-99.0%$0.00N/A0.0060

Related Companies and Tools


This page (NASDAQ:NEXI) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners